Compare RBCAA & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RBCAA | IRMD |
|---|---|---|
| Founded | 1974 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.3B |
| IPO Year | 1998 | 2014 |
| Metric | RBCAA | IRMD |
|---|---|---|
| Price | $76.44 | $83.83 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | N/A | ★ $116.00 |
| AVG Volume (30 Days) | 69.7K | ★ 79.3K |
| Earning Date | 04-23-2026 | 05-01-2026 |
| Dividend Yield | ★ 2.40% | 0.90% |
| EPS Growth | N/A | ★ 16.67 |
| EPS | 0.77 | ★ 1.75 |
| Revenue | ★ $417,495,000.00 | $83,814,000.00 |
| Revenue This Year | $3.93 | $12.38 |
| Revenue Next Year | N/A | $11.31 |
| P/E Ratio | $97.52 | ★ $50.62 |
| Revenue Growth | 8.50 | ★ 14.43 |
| 52 Week Low | $63.97 | $50.36 |
| 52 Week High | $78.00 | $107.90 |
| Indicator | RBCAA | IRMD |
|---|---|---|
| Relative Strength Index (RSI) | 59.37 | 26.29 |
| Support Level | $66.20 | $82.64 |
| Resistance Level | $76.74 | $87.54 |
| Average True Range (ATR) | 2.37 | 3.18 |
| MACD | 0.11 | -0.64 |
| Stochastic Oscillator | 85.28 | 0.00 |
Republic Bancorp Inc operates as a financial institution that provides both traditional and non-traditional banking products through five reportable segments. It has traditional banking, which generates the majority of revenue, Warehouse Lending, Tax Refund Solutions (TRS), Republic Payment Solutions segment, and Republic Credit Solutions (RCS) business segments. The business activities of these segments include retail mortgage and commercial lending, construction and land development lending, internet lending, correspondent and indirect lending, and also private banking, treasury management services, internet, and mobile banking, bank acquisitions, short-term revolving credit facilities, fixed-term residential real estate loans, and receipt and payment of federal.
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.